TY - JOUR
T1 - Late renal toxicity in patient with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
T2 - A case report and literature review
AU - Pham, Bryan
AU - Kwon, Sue Min
AU - Castillo, Dan Ran
AU - Majeed, Yasamin
AU - Ahmad, Sarmad
AU - Hou, Jean
AU - Ganesan, Lakshmi
AU - Mohammad, Sharif
AU - Cao, Huynh
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/12
Y1 - 2022/12
KW - Hurthle cell variant
KW - Lenvatinib
KW - drug induced thrombotic microangiopathy
KW - follicular thyroid carcinoma
KW - thrombotic microangiopathy
KW - tyrosine kinase inhibitors
KW - Diabetes Mellitus, Type 2/chemically induced
KW - Humans
KW - Quinolines/adverse effects
KW - Phenylurea Compounds/adverse effects
KW - Thyroid Neoplasms/drug therapy
KW - Protein Kinase Inhibitors/adverse effects
KW - Iodine Radioisotopes/adverse effects
KW - Female
KW - Antineoplastic Agents/adverse effects
KW - Aged
KW - Adenocarcinoma/drug therapy
UR - https://www.scopus.com/pages/publications/85127745887
UR - https://www.scopus.com/pages/publications/85127745887#tab=citedBy
UR - https://www.mendeley.com/catalogue/aa751e6d-c236-383d-9645-d14eaa240322/
U2 - 10.1177/10781552221092329
DO - 10.1177/10781552221092329
M3 - Article
C2 - 35369811
AN - SCOPUS:85127745887
SN - 1078-1552
VL - 28
SP - 1930
EP - 1935
JO - Journal of Oncology Pharmacy Practice
JF - Journal of Oncology Pharmacy Practice
IS - 8
ER -